(Q51484477)

English

Effects of rosiglitazone and pioglitazone combined with metformin on the prothrombotic state of patients with type 2 diabetes mellitus and metabolic syndrome.

scientific article published in September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Effects of rosiglitazone and pioglitazone combined with metformin on the prothrombotic state of patients with type 2 diabetes mellitus and metabolic syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

metabolic syndrome

1 reference

based on heuristic

inferred from title

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

Giuseppe Derosa

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

A Dangelo

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

P D Ragonesi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

L Ciccarelli

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

M N Piccinni

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

F Pricolo

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

S Salvadeo

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

L Montagna

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

A Gravina

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

I Ferrari

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

S Paniga

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

A F G Cicero

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Journal of International Medical Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

545-555

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17133785%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Atherothrombosis, inflammation, and diabetes

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

Age-related changes in risk factor effects on the incidence of thromboembolic and hemorrhagic stroke

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

Inflammation and emerging risk factors in diabetes mellitus and atherosclerosis

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

Dietary glycemic load and atherothrombotic risk

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

Plasminogen activator inhibitor-1: physiologic role, regulation, and the influence of common pharmacologic agents

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

The Glycosylation of Hemoglobin: Relevance to Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

Determination of total serum insulin (IRI) in insulin-treated diabetic patients

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

The prevention or delay of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

Improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

Combining sulfonylureas and other oral agents

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

Rosiglitazone inhibits the insulin-mediated increase in PAI-1 secretion in human abdominal subcutaneous adipocytes

1 reference

https://api.crossref.org/works/10.1177%2F147323000603400513

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51484477&oldid=1512246266"